A simple and quick test developed by scientists can help diagnose stomach cancer, says study.
Scientists from Israel and China found the test was 90 percent accurate at detecting and distinguishing cancers from other stomach complaints in 130 patients.
The Splendid Stomach - Animation
Stomach is the organ where food is mixed, stored and partially digested.
Advertisement
According to the British Journal of Cancer, the test could revolutionise and speed up the way this cancer is diagnosed, the BBC reported.
About 7,000 UK people develop stomach cancer each year and most have an advanced stage of the disease.
Two-fifths of patients survive for at least a year, but only a fifth are still alive after five years, despite treatment.
![Aspirin Lowers Odds of Bowel and Stomach Cancers]( "Aspirin Lowers Odds of Bowel and Stomach Cancers")
Taking aspirin every other day cuts the risk of bowel and stomach cancers by more than 40 percent, states study.
Currently doctors diagnose stomach cancer by taking a biopsy of the stomach lining using a probe and a flexible camera passed via mouth and down the gullet.
The new test looks for chemical profiles in exhaled breath that are unique to patients with stomach cancer.
Cancer appears to give off a signature smell of volatile organic compounds that can be detected using the right technical medical kit - and perhaps even dogs.
The science behind the test itself is not new - many researchers have been working on the possibility of breath tests for a number of cancers, including lung.
But the work by Prof Hossam Haick, of the Israel Institute of Technology, suggests it is a good way to spot stomach cancer.
In the study, 37 of the patients had stomach cancer, 32 had stomach ulcers and 61 had other stomach complaints.
As well as accurately distinguishing between these conditions 90 percent of the time, the breath test could tell the difference between early and late-stage stomach cancers.
Source: ANI
Two-fifths of patients survive for at least a year, but only a fifth are still alive after five years, despite treatment.
Aspirin Lowers Odds of Bowel and Stomach Cancers
Taking aspirin every other day cuts the risk of bowel and stomach cancers by more than 40 percent, states study.
Advertisement
Currently doctors diagnose stomach cancer by taking a biopsy of the stomach lining using a probe and a flexible camera passed via mouth and down the gullet.
The new test looks for chemical profiles in exhaled breath that are unique to patients with stomach cancer.
Cancer appears to give off a signature smell of volatile organic compounds that can be detected using the right technical medical kit - and perhaps even dogs.
The science behind the test itself is not new - many researchers have been working on the possibility of breath tests for a number of cancers, including lung.
But the work by Prof Hossam Haick, of the Israel Institute of Technology, suggests it is a good way to spot stomach cancer.
In the study, 37 of the patients had stomach cancer, 32 had stomach ulcers and 61 had other stomach complaints.
As well as accurately distinguishing between these conditions 90 percent of the time, the breath test could tell the difference between early and late-stage stomach cancers.
Source: ANI
AIDS Patients Face Risk for Esophageal, Stomach Cancers, Says Study
In a recent study it was found that people with AIDS are at an increased risk for developing esophageal and stomach carcinoma.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Lipid nanoparticles use M13, a potent anti-ulcerative colitis compound, in an oral formulation to combat colitis-linked cancer.
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
